- Nattokinase
-
- $0.00 / 1KG
-
2024-08-28
- CAS:133876-92-3
- Min. Order: 1KG
- Purity: 98% TLC
- Supply Ability: 1000KG
- Nattokinase
-
- $8.70 / 1kg
-
2024-08-20
- CAS:133876-92-3
- Min. Order: 10kg
- Purity: 99%
- Supply Ability: 10000kg
|
| Nattokinase Basic information |
Product Name: | Nattokinase | Synonyms: | Nattokinase;Nattoesse Haruno-Ogawa;4-(Carboxymethyl)-2-[(1R)-1-{[N-(2,5-dichlorobenzoyl)glycyl]amino}-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid;4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic;Liposomal NATTOKINASE, NATTOKINASE NanoEmulsion, NanoActive NATTOKINASE, Oil-Soluble NATTOKINASE;4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid;Nattokinase (peptidolytic);NattoLife | CAS: | 133876-92-3 | MF: | C20H23BCl2N2O9 | MW: | 517.12162 | EINECS: | 229-880-6 | Product Categories: | 133876-92-3 | Mol File: | 133876-92-3.mol | ![Nattokinase Structure](CAS/20180808/GIF/133876-92-3.gif) |
| Nattokinase Chemical Properties |
form | Solid | color | White to off-white | InChIKey | YTXSYWAKVMZICI-VVSYKVCONA-N | SMILES | O1C(=O)CC(CC(O)=O)(C(O)=O)OB1[C@@H](NC(CNC(=O)C1=CC(Cl)=CC=C1Cl)=O)CC(C)C |&1:14,r| |
| Nattokinase Usage And Synthesis |
Chemical Properties | Nattokinase is an enzyme (a protein that speeds up biochemical reactions) that is extracted from a popular Japanese food called natto. Natto is boiled soybeans that have been fermented with a bacterium called Bacillus natto. | Uses | Although nattokinase is promoted for use as a fibrinolytic and thrombolytic agent, clinical trials are lacking to support such use. There is also no substantial evidence that nattokinase lowers blood pressure in hypertension. | Mechanism of action | Nattokinase decreases the ability of blood to clot. This "thins the blood" and might protect against conditions caused by blood clots such as stroke, heart attack, and others. | Side effects | Small, short-term trials evaluating nattokinase reported no adverse reactions. There is a theoretical risk of bleeding, based on a case report of acute cerebellar hemorrhage in a patient with a history of ischemic stroke. Thrombosis was reported after substitution of nattokinase for warfarin in a patient with a mechanical aortic valve. Rare cases of late-onset anaphylaxis with natto have been attributed to poly-gamma-glutamic acid, a product of the fermentation process that may be present in nattokinase supplements. |
| Nattokinase Preparation Products And Raw materials |
|